4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000135
Chairperson & CEO sold 9,500 shares at an average $487.54 ($4,631,619)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,910 | $135.42 | $1,206,592 | 333,353 | I |
| 2026-09-03 | Exercise or conversion : show line 2 in the form 10b5-1 | +590 | $117.76 | $69,478 | 333,943 | I |
| 2026-09-03 | Sale : show line 3 in the form 10b5-1 | −200 | $479.07 | $95,813 | 333,743 | I |
| 2026-09-03 | Sale : show line 4 in the form 10b5-1 | −440 | $480.53 | $211,431 | 333,303 | I |
| 2026-09-03 | Sale : show line 5 in the form 10b5-1 | −600 | $481.47 | $288,884 | 332,703 | I |
| 2026-09-03 | Sale : show line 6 in the form 10b5-1 | −400 | $482.35 | $192,938 | 332,303 | I |
| 2026-09-03 | Sale : show line 7 in the form 10b5-1 | −80 | $483.69 | $38,695 | 332,223 | I |
| 2026-09-03 | Sale : show line 8 in the form 10b5-1 | −240 | $485.16 | $116,438 | 331,983 | I |
| Open-market sales · 9,500 sh · avg $487.54 · $4,631,619 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-03 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option | −8,910 | 0 | I |
| 2026-09-03 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option | −590 | 499,410 | I |
Loading xslF345X06/primarydocument.xml…